跳至主要内容
临床试验/NCT00899405
NCT00899405招募中不适用

EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood

University of California, Davis2 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2004年5月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
800
试验地点
2
主要终点
Mutational status of the EGFR pathway

研究概览

简要总结

RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.

详细描述

OBJECTIVES:

  • Examine the mutational status of the EGFR pathway in tumor and blood samples from patients with lung cancer.
  • Correlate the EGFR pathway mutations in these samples with clinical outcomes of these patients.

OUTLINE: Archived tumor tissue and blood samples are analyzed via PCR to detect EGFR pathway mutations in DNA.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DISEASE CHARACTERISTICS:
  • Histologically or cytologically confirmed lung cancer
  • PATIENT CHARACTERISTICS:
  • Not specified
  • PRIOR CONCURRENT THERAPY:
  • May have received prior EGFR inhibitors

排除标准

  • 未提供

结局指标

主要结局

Mutational status of the EGFR pathway

时间窗: up to 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Studying Tumor Tissue Samples and Blood Samples to... | 临床试验